🍾 Beverages
✦ AI
The spirits industry has suffered from post-Covid normalisation, shifting consumer preferences and growing GLP-1 drug influence on alcohol consumption since 2023. Diageo cut its guidance multiple times in FY2025 and FY2026, reporting weak to negative organic growth. Open platform predictions for Pernod Ricard, Brown-Forman and Campari consistently show organic declines; the pattern is sectorally broad. No direct prediction market for this forecast; sector dynamics and Diageo's own H1 FY2026 profit warning support approximately 68% probability for continued organic revenue decline in H1 FY2027.
🍾 Beverages
✦ AI
Coca-Cola has delivered organic revenue growth well above 4% in four consecutive fiscal years (FY2022: +11%, FY2023: +12%, FY2024: +6%, FY2025: ~5%; Bloomberg). The 4% threshold for FY2026 sits well below the historical mean, providing substantial buffer. KO benefits from strong non-alcoholic beverages pricing power and EM volume recovery. Risks: sustained North American consumer pressure at premium prices, FX headwinds (BRL, MXN), China volume softness. No Polymarket market for KO annual revenue; own fundamental analysis based on historical trend and macro backdrop (VIX 16.34).
🍾 Beverages
✦ AI
Pernod Ricard (brands: Absolut, Jameson, Chivas, Martell, Ballantine's) reported on August 27, 2026 for FY2025/26 (July 2025–June 2026) an organic net revenue decline of –3.9% YoY, driven by persistent China weakness in Cognac (Martell) and normalized US whisky demand. For H1 FY2026/27 (July–December 2026), a trend reversal remains unlikely: China consumer sentiment remains subdued despite stimulus measures, US tariffs on European spirits continue to weigh, and the premium spirits category is growing more slowly globally. Sector peers Rémy Cointreau, Brown-Forman, Diageo, and Campari all reported negative organic growth rates in their most recent half-year results. H1 report expected ca. February 2027 (historical pattern: H1 FY2025/26 reported February 19, 2026). No Polymarket market found; own estimate: 60%.
🍾 Beverages
✦ AI
Diageo closed FY2026 (year to June 30, 2026) with organic net sales down 2.0%; H1 FY2026 showed an even sharper -2.8%. North America (-8.4%) and Asia Pacific (-6.3%) remain structurally weak. Despite the $1bn cost programme and partial recovery in Europe and Latin America, another negative organic net sales print for H1 FY2027 is more likely than a full reversal — the global premium spirits market recovers slowly. No Polymarket market; estimated 57% from FY2026 data.
🍾 Beverages
✦ AI
AB InBev has recovered from Bud Light controversies (2023–2024) in US core markets and benefits strongly from emerging markets (APAC, Africa, Latin America). FY2025 achieved organic revenue growth of approximately +2.7%; the analyst consensus for FY2026 is +3.0–3.5% (Bloomberg, August 2026). Headwinds: macroeconomic slowdown in China and consumer restraint in Europe. No Polymarket market available; own estimate ~45%. No existing open prediction for AB InBev.
🍾 Beverages
✦ AI
Boston Beer generated $1.96 billion in net revenue in 2025 (–2.38% YoY). Exceeding $2.0 billion in 2026 requires approximately +2% growth. Headwinds: hard seltzer shrank 5% in 2025 and structural category decline continues. Tailwinds: RTD spirits are growing; Boston Beer holds significant RTD market share with Twisted Tea and Truly (>85% of volume in Beyond Beer). The wide EPS guidance of $8.50–$11.00 per share reflects substantial planning uncertainty. Results are typically reported in February 2027 (Q4/FY2026 release). No Polymarket market. The category mix shift could just suffice to reverse the revenue decline.
🍾 Beverages
✦ AI
Pernod Ricard reported a -3.9% organic net sales decline for FY2026 (fiscal year to June 30, 2026), but a significant improvement from H1 FY26 (-5.9%) to H2 FY26 (-1.3%). The company guides +3–6% p.a. organic growth for FY27–29. H1 FY27 (July–December 2026) is seasonally the strongest period for premium spirits (Christmas season). The recovery trajectory is clear, but US market weakness and China uncertainty remain risks. The 2.0% threshold is below the guidance range, but not automatic: a return to positive growth territory appears plausible; exceeding +2% in H1 is possible but uncertain.